164 related articles for article (PubMed ID: 28103784)
1. The Multi-faceted Profile of Corticotropin-releasing Factor (CRF) Family of Neuropeptides and of their Receptors on the Paracrine/Local Regulation of the Inflammatory Response.
Dermitzaki E; Venihaki M; Tsatsanis C; Gravanis A; Avgoustinaki PD; Liapakis G; Margioris AN
Curr Mol Pharmacol; 2018; 11(1):39-50. PubMed ID: 28103784
[TBL] [Abstract][Full Text] [Related]
2. Corticotropin-releasing factor family and its receptors: pro-inflammatory or anti-inflammatory targets in the periphery?
Zhu H; Wang J; Li J; Li S
Inflamm Res; 2011 Aug; 60(8):715-21. PubMed ID: 21476084
[TBL] [Abstract][Full Text] [Related]
3. Corticotropin-releasing factor in antinociception and inflammation.
Schäfer M; Mousa SA; Stein C
Eur J Pharmacol; 1997 Mar; 323(1):1-10. PubMed ID: 9105870
[TBL] [Abstract][Full Text] [Related]
4. Corticotropin releasing factor receptor 1 (CRF1) and CRF2 agonists exert an anti-inflammatory effect during the early phase of inflammation suppressing LPS-induced TNF-alpha release from macrophages via induction of COX-2 and PGE2.
Tsatsanis C; Androulidaki A; Dermitzaki E; Gravanis A; Margioris AN
J Cell Physiol; 2007 Mar; 210(3):774-83. PubMed ID: 17117478
[TBL] [Abstract][Full Text] [Related]
5. The corticotropin-releasing factor (CRF) family of neuropeptides in inflammation: potential therapeutic applications.
Gravanis A; Margioris AN
Curr Med Chem; 2005; 12(13):1503-12. PubMed ID: 15974983
[TBL] [Abstract][Full Text] [Related]
6. Determinants of corticotropin releasing factor. Receptor selectivity of corticotropin releasing factor related peptides.
Mazur AW; Wang F; Tscheiner M; Donnelly E; Isfort RJ
J Med Chem; 2004 Jun; 47(13):3450-4. PubMed ID: 15189041
[TBL] [Abstract][Full Text] [Related]
7. The calcineurin-nuclear factor of activated T cells signaling pathway mediates the effect of corticotropin releasing factor and urocortins on catecholamine synthesis.
Dermitzaki E; Tsatsanis C; Gravanis A; Margioris AN
J Cell Physiol; 2012 May; 227(5):1861-72. PubMed ID: 21702050
[TBL] [Abstract][Full Text] [Related]
8. Corticotropin-releasing factor and its receptors in the brain of rats with insulin and corticosterone deficits.
Huang Q; Timofeeva E; Richard D
J Mol Endocrinol; 2006 Oct; 37(2):213-26. PubMed ID: 17032740
[TBL] [Abstract][Full Text] [Related]
9. Pre-clinical evidence that corticotropin-releasing factor (CRF) receptor antagonists are promising targets for pharmacological treatment of alcoholism.
Lowery EG; Thiele TE
CNS Neurol Disord Drug Targets; 2010 Mar; 9(1):77-86. PubMed ID: 20201818
[TBL] [Abstract][Full Text] [Related]
10. Regulation of corticotropin-releasing factor and urocortin 2/3 mRNA by leptin in hypothalamic N39 cells.
Yamagata S; Kageyama K; Akimoto K; Watanuki Y; Suda T; Daimon M
Peptides; 2013 Dec; 50():1-7. PubMed ID: 24083959
[TBL] [Abstract][Full Text] [Related]
11. The CRF Family of Neuropeptides and their Receptors - Mediators of the Central Stress Response.
Dedic N; Chen A; Deussing JM
Curr Mol Pharmacol; 2018; 11(1):4-31. PubMed ID: 28260504
[TBL] [Abstract][Full Text] [Related]
12. Expression of urocortin and corticotropin-releasing factor receptor subtypes in the human heart.
Kimura Y; Takahashi K; Totsune K; Muramatsu Y; Kaneko C; Darnel AD; Suzuki T; Ebina M; Nukiwa T; Sasano H
J Clin Endocrinol Metab; 2002 Jan; 87(1):340-6. PubMed ID: 11788672
[TBL] [Abstract][Full Text] [Related]
13. Urocortin in the synovial tissue of patients with rheumatoid arthritis.
Uzuki M; Sasano H; Muramatsu Y; Totsune K; Takahashi K; Oki Y; Iino K; Sawai T
Clin Sci (Lond); 2001 Jun; 100(6):577-89. PubMed ID: 11352772
[TBL] [Abstract][Full Text] [Related]
14. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor.
Vaughan J; Donaldson C; Bittencourt J; Perrin MH; Lewis K; Sutton S; Chan R; Turnbull AV; Lovejoy D; Rivier C
Nature; 1995 Nov; 378(6554):287-92. PubMed ID: 7477349
[TBL] [Abstract][Full Text] [Related]
15. The peripheral corticotropin releasing factor family's role in vasculitis.
Zhu C; Li S
Vascul Pharmacol; 2024 Mar; 154():107275. PubMed ID: 38184094
[TBL] [Abstract][Full Text] [Related]
16. Role of peripheral corticotropin-releasing factor and urocortin II in intestinal inflammation and motility in terminal ileum.
la Fleur SE; Wick EC; Idumalla PS; Grady EF; Bhargava A
Proc Natl Acad Sci U S A; 2005 May; 102(21):7647-52. PubMed ID: 15883387
[TBL] [Abstract][Full Text] [Related]
17. Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors.
Reyes TM; Lewis K; Perrin MH; Kunitake KS; Vaughan J; Arias CA; Hogenesch JB; Gulyas J; Rivier J; Vale WW; Sawchenko PE
Proc Natl Acad Sci U S A; 2001 Feb; 98(5):2843-8. PubMed ID: 11226328
[TBL] [Abstract][Full Text] [Related]
18. Mast cells as targets of corticotropin-releasing factor and related peptides.
Theoharides TC; Donelan JM; Papadopoulou N; Cao J; Kempuraj D; Conti P
Trends Pharmacol Sci; 2004 Nov; 25(11):563-8. PubMed ID: 15491778
[TBL] [Abstract][Full Text] [Related]
19. Corticotropin-releasing factor (CRF) receptor type 2 in the human stomach: protective biological role by inhibition of apoptosis.
Chatzaki E; Lambropoulou M; Constantinidis TC; Papadopoulos N; Taché Y; Minopoulos G; Grigoriadis DE
J Cell Physiol; 2006 Dec; 209(3):905-11. PubMed ID: 16972272
[TBL] [Abstract][Full Text] [Related]
20. Functional Significance of the Signal Peptides of Corticotropin-Releasing Factor Receptors.
Schulein R; Gibert A; Rutz C
Curr Mol Pharmacol; 2017; 10(4):311-317. PubMed ID: 28240192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
